Study of serum EGFR, HER-2/neu,VEGF in metastatic breast cancer patients treated with taxanes.

@article{Labropoulos2004StudyOS,
  title={Study of serum EGFR, HER-2/neu,VEGF in metastatic breast cancer patients treated with taxanes.},
  author={Stefanos V Labropoulos and George Fountzilas and Savvas Papadopoulos and Maria Karina and M Xylouri and A Doudoulakakis and Sonia Chalkidou and Evangelia Razis},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2004},
  volume={22 14_suppl},
  pages={757}
}
757 Background: Novel drugs with activity against EGFR,Her-2/neu,VEGF are used in clinical practice. Previous studies have examined the possible prognostic and predictive role of soluble EGFR, Her-2/neu,VEGF, in metastatic breast cancer(MBC) with various results.We examine whether their combined measurement has any prognostic or predictive role. METHODS… CONTINUE READING